Impact of radiation on the incidence and management of ureteroenteric strictures: a contemporary single center analysis.


Journal

BMC urology
ISSN: 1471-2490
Titre abrégé: BMC Urol
Pays: England
ID NLM: 100968571

Informations de publication

Date de publication:
04 Aug 2021
Historique:
received: 21 02 2021
accepted: 06 07 2021
entrez: 5 8 2021
pubmed: 6 8 2021
medline: 1 1 2022
Statut: epublish

Résumé

Ureteroenteric stricture incidence has been reported as high as 20% after urinary diversion. Many patients have undergone prior radiotherapy for prostate, urothelial, colorectal, or gynecologic malignancy. We sought to evaluate the differences between ureteroenteric stricture occurrence between patients who had radiation prior to urinary diversion and those who did not. An IRB-approved cystectomy database was utilized to identify ureteroenteric strictures among 215 patients who underwent urinary diversion at a single academic center between 2016 and 2020. Chart abstraction was conducted to determine the presence of confirmed stricture in these patients, defined as endoscopic diagnosis or definitive imaging findings. Strictures due to malignant ureteral recurrence were excluded (3 patients). Statistical analysis was performed using chi squared test, t-test, and Wilcoxon Rank-Sum Test, logistic regression, and Kaplan-Meier analysis of stricture by cancer type. 65 patients had radiation prior to urinary diversion; 150 patients did not have a history of radiation therapy. Benign ureteroenteric stricture rate was 5.3% (8/150) in the non-radiated cohort and 23% (15/65) in the radiated cohort (p =  < 0.001). Initial management of stricture was percutaneous nephrostomy (PCN) in 78% (18/23) and the remaining 22% (5/23) were managed with primary retrograde ureteral stent placement. Long term management included ureteral reimplantation in 30.4% (7/23). Our study demonstrates a significant increase in rate of ureteroenteric strictures in radiated patients as compared to non-radiated patients. The insult of radiation on the ureteral microvascular supply is likely implicated in the cause of these strictures. Further study is needed to optimize surgical approach such as utilization of fluorescence angiography for open and robotic approaches.

Sections du résumé

BACKGROUND BACKGROUND
Ureteroenteric stricture incidence has been reported as high as 20% after urinary diversion. Many patients have undergone prior radiotherapy for prostate, urothelial, colorectal, or gynecologic malignancy. We sought to evaluate the differences between ureteroenteric stricture occurrence between patients who had radiation prior to urinary diversion and those who did not.
METHODS METHODS
An IRB-approved cystectomy database was utilized to identify ureteroenteric strictures among 215 patients who underwent urinary diversion at a single academic center between 2016 and 2020. Chart abstraction was conducted to determine the presence of confirmed stricture in these patients, defined as endoscopic diagnosis or definitive imaging findings. Strictures due to malignant ureteral recurrence were excluded (3 patients). Statistical analysis was performed using chi squared test, t-test, and Wilcoxon Rank-Sum Test, logistic regression, and Kaplan-Meier analysis of stricture by cancer type.
RESULTS RESULTS
65 patients had radiation prior to urinary diversion; 150 patients did not have a history of radiation therapy. Benign ureteroenteric stricture rate was 5.3% (8/150) in the non-radiated cohort and 23% (15/65) in the radiated cohort (p =  < 0.001). Initial management of stricture was percutaneous nephrostomy (PCN) in 78% (18/23) and the remaining 22% (5/23) were managed with primary retrograde ureteral stent placement. Long term management included ureteral reimplantation in 30.4% (7/23).
CONCLUSIONS CONCLUSIONS
Our study demonstrates a significant increase in rate of ureteroenteric strictures in radiated patients as compared to non-radiated patients. The insult of radiation on the ureteral microvascular supply is likely implicated in the cause of these strictures. Further study is needed to optimize surgical approach such as utilization of fluorescence angiography for open and robotic approaches.

Identifiants

pubmed: 34348684
doi: 10.1186/s12894-021-00869-6
pii: 10.1186/s12894-021-00869-6
pmc: PMC8336081
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101

Informations de copyright

© 2021. The Author(s).

Références

Ther Adv Urol. 2019 Apr 04;11:1756287219839631
pubmed: 31057669
Urology. 2001 Dec;58(6):909-13
pubmed: 11744456
Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):887-894
pubmed: 30419309
World J Urol. 2021 Feb;39(2):473-479
pubmed: 32303901
J Urol. 2017 Sep;198(3):567-574
pubmed: 28257782
Urol Int. 2018;100(1):18-24
pubmed: 28817820
Scand J Urol. 2016 Dec;50(6):439-444
pubmed: 27686879
Urol Oncol. 2015 Feb;33(2):65.e1-8
pubmed: 25023788
Transl Androl Urol. 2020 Feb;9(1):142-150
pubmed: 32055478
Urol Clin North Am. 2018 Feb;45(1):79-90
pubmed: 29169453
J Urol. 2013 Sep;190(3):923-7
pubmed: 23454159
Int J Urol. 2017 May;24(5):390-395
pubmed: 28295645
Urology. 2020 Oct;144:130-135
pubmed: 32653565
Can Urol Assoc J. 2015 Nov-Dec;9(11-12):E921-4
pubmed: 26788241
Urology. 2020 Jan;135:57-65
pubmed: 31618656
J Endourol. 2016 Jan;30(1):83-91
pubmed: 26405852
Cancer Invest. 1989;7(3):287-94
pubmed: 2477120
BJU Int. 2019 Aug;124(2):302-307
pubmed: 30815976
Eur Urol. 2019 Feb;75(2):294-299
pubmed: 30091420
Urology. 2021 May;151:107-112
pubmed: 32961221
Nat Rev Urol. 2016 Aug;13(8):447-55
pubmed: 27349367
J Urol. 2011 Feb;185(2):562-7
pubmed: 21168867

Auteurs

Clinton T Yeaman (CT)

Department of Urology, UVA Medical Center, Fontaine Research Park, 500 Ray C. Hunt Drive, Charlottesville, VA, 22908, USA. Cy5eb@virginia.edu.

Andrew Winkelman (A)

University of Virginia School of Medicine, Charlottesville, VA, USA.

Kimberly Maciolek (K)

Department of Urology, UVA Medical Center, Fontaine Research Park, 500 Ray C. Hunt Drive, Charlottesville, VA, 22908, USA.

Mei Tuong (M)

Department of Urology, UVA Medical Center, Fontaine Research Park, 500 Ray C. Hunt Drive, Charlottesville, VA, 22908, USA.

Perri Nelson (P)

Department of Urology, UVA Medical Center, Fontaine Research Park, 500 Ray C. Hunt Drive, Charlottesville, VA, 22908, USA.

Chandler Morris (C)

Department of Urology, UVA Medical Center, Fontaine Research Park, 500 Ray C. Hunt Drive, Charlottesville, VA, 22908, USA.

Stephen Culp (S)

Department of Urology, UVA Medical Center, Fontaine Research Park, 500 Ray C. Hunt Drive, Charlottesville, VA, 22908, USA.
University of Virginia School of Medicine, Charlottesville, VA, USA.

Sumit Isharwal (S)

Department of Urology, UVA Medical Center, Fontaine Research Park, 500 Ray C. Hunt Drive, Charlottesville, VA, 22908, USA.
University of Virginia School of Medicine, Charlottesville, VA, USA.

Tracey L Krupski (TL)

Department of Urology, UVA Medical Center, Fontaine Research Park, 500 Ray C. Hunt Drive, Charlottesville, VA, 22908, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH